| abstract |
Tumor-associated peptide, where the peptide shows the ability to bind a molecule of the major human histocompatibility complex (MHC) class I, selected from, a) an amino acid sequence composed of the sequence SEQ ID No. 303 (TMLARLASA) , b) a peptide according to a), in which an amino acid is substituted by another amino acid with similar chemical properties, and c) a peptide according to a) or b), in which the N and / or C end has another amino acid. |